Christine Harrison

Christine Harrison has extensive experience in corporate finance and strategic planning within the pharmaceutical industry, currently serving as Executive Director of Corporate Planning & Strategy at Eisai US since July 2019. Previous roles include Senior Director of US Corporate Planning and Finance Director for the Neurology Business Group at Eisai, as well as Associate Director at Novartis and Associate Director of FP&A at Mallinckrodt Pharmaceuticals. Christine's earlier career includes significant positions in finance management at Bayer HealthCare, Schering Plough, McKinsey & Company, and Daiwa Securities. Christine holds an MBA in Finance from Fordham Gabelli School of Business.